RNA Analysis / Transcriptomics Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027

Comments · 277 Views

Rising prevalence of cancer, diabetes, and hepatitis B, and growing focus on various drug development initiatives are key factors boosting revenue growth of the global market

The latest and updated research report on the Global RNA Analysis / Transcriptomics Market covers a comprehensive overview of the RNA Analysis / Transcriptomics market, future economic condition, competitive landscape mapping, supply and demand trends, and production and consumption analysis. The report also covers the influence of the COVID-19 pandemic on the RNA Analysis / Transcriptomics market. The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact. The report encompasses the historical data, company overview, financial standing, and necessary information about the new and key players of the market.

Additionally, the report also gives an insight into product portfolios, costs, sales, production capacities, and market players. Raw materials, demand analysis, product flow, and distribution channels have been studied and surveyed extensively in this research report. The key growth trends and opportunities are offered through a thorough investigation and examination of the market. A detailed course of development is offered in the report along with insights into businesses connected with it, which include firms, industries, organizations, vendors, and local manufacturers.

 

Get a sample of the report : https://www.emergenresearch.com/request-sample/610

Reagents segment is expected to register a revenue CAGR of 14.0% over the forecast period. This can be attributed to rising demand for high-quality reagents and growing research and development activities in the pharmaceutical sector.

Asia Pacific market revenue is expected to continue to register the fastest CAGR throughout the forecast period, which can be attributed to rising number of biotechnology and pharmaceutical companies and increasing focus on drug development.

Key players operating in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.

This analysis assesses all elements of a transcript, such as non-coding RNAs, mRNAs, and microRNAs, to identify the transcriptional structure of genes and quantify each transcript's changing behavior at the development stage. Transcriptomics has a variety of applications in diagnostics and disease analysis. Transcriptome analysis has been widely used to study heterogeneity of tumors, classify tumors into molecular subtypes, and examine treatment therapy and patient outcomes.Commonly applied transcriptome analysis methods are hybridization-based microarray, real-time PCR, NGS-based RNA-sequencing (RNA-seq) methods, RNA interference, and bioinformatics tools. Growing need to analyze a large number of genes to better understand gene-to-drug interactions is expected to increase the application of transcriptomic technologies in drug development and discovery applications.

Competitive Outlook:

The global RNA Analysis / Transcriptomics market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector. 

 Key Questions Answered in the Report:

What is the growth rate of the RNA Analysis / Transcriptomics market? What is the anticipated market valuation of RNA Analysis / Transcriptomics industry by 2027?

What are the key growth driving and restraining factors of the RNA Analysis / Transcriptomics market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the RNA Analysis / Transcriptomics industry over the forecast period?

Which region is expected to show significant growth in the coming years?

Request a discount on the report : https://www.emergenresearch.com/request-discount/610

For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:

Product Outlook (Revenue: USD Billion; 2018–2028)

 

  • Reagents
  • Instruments
  • Software
  • Service

 

Technology Outlook (Revenue: USD Billion; 2018–2028)

  • Microarrays
  • Polymerase Chain Reaction
  • RNA Sequencing
  • RNA Interference

Application Outlook (Revenue: USD Billion; 2018–2028)

  • Clinical Diagnostics
    1. Toxicogenomics
    2. Drug Discovery
    3. Comparative Transcriptomics

End-use Outlook (Revenue: USD Billion; 2018–2028)

  • Hospitals
  • Academic Research Institutes
  • Pharmaceutical Biotechnology Companies
  • Contract Research Organizations

Market Taxonomy:

Chapter 1: Methodology Scope

  • Definition and forecast parameters
  • Methodology and forecast parameters
  • Data Sources


Chapter 2:

Executive Summary

  • Business trends
  • Regional trends
  • Product trends
  • End-use trends


Chapter 3:

Industry Insights

  • Industry segmentation
  • Industry landscape
  • Vendor matrix
  • Technological and innovation landscape


Chapter 4:

Regional Landscape

Chapter 5:

Company Profile

  • Business Overview
  • Financial Data
  • Product Landscape
  • Strategic Outlook

Regional Outlook (Revenue: USD Billion; 2018–2028)

  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. U.K.
    4. BENELUX
    5. Italy
    6. Spain
    7. Russia
    8. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of MEA

To know more about the report:  https://www.emergenresearch.com/industry-report/rna-transcriptomics-market

Related reports:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

In-Vitro Fertilization Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

 

Comments